Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Suboxone versus methadone for the detoxification of patients addicted to prescription opioids: a review of comparative clinical effectiveness, safety, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary with Critical Appraisal. 2014 Authors' conclusions One RCT suggests that Suboxone and methadone were similar with regards to treatment retention and decreasing use of other opioids in patients with nonmalignant chronic pain and an addiction to a prescription opioid. One guideline suggests that a daily dose of Suboxone for 1 to 3 days should eliminate signs and symptoms of opioid withdrawal, suppress opioid cravings, and eliminate illicit opioid use in adults. Indexing Status Subject indexing assigned by CRD MeSH Buprenorphine; Humans; Methadone; Naloxone; Opioid-Related Disorders Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000815 Date abstract record published 16/07/2014 |
